Edition:
India

Sanofi SA (SASY.PA)

SASY.PA on Paris Stock Exchange

93.50EUR
20 Feb 2020
Change (% chg)

-- (--)
Prev Close
€93.50
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
2,070,152
52-wk High
€95.06
52-wk Low
€71.74

Select another date:

Tue, Feb 18 2020

Sanofi teams up with U.S. agency against coronavirus

PARIS French drugmaker Sanofi is working with a U.S. government agency to develop a vaccine against the new coronavirus from China, saying it could have a candidate ready for clinical trials within a year.

Sanofi partners with U.S. agency to develop coronavirus vaccine

PARIS, Feb 18 Sanofi said on Tuesday it was working with the Biomedical Advanced Research and Development Authority (BARDA) of the U.S. Health Department to develop a vaccine against the new coronavirus from China.

Sanofi trims executive committee to 10 members after four departures

PARIS, Feb 12 Four members of Sanofi's executive committee are to leave the company, a spokesman told Reuters on Wednesday, as the French drugmaker refocuses on internal research, rare diseases and vaccines under new Chief Executive Paul Hudson.

BRIEF-Biocorp FY Revenue Up At 8.45 Million Euros

* BIOCORP PRODUCTION SA SAYS STRONG CASH POSITION AT EUR 2.007 MILLION ON DECEMBER 31, 2019

French drugmaker Sanofi working on coronavirus initiative

PARIS French drugmaker Sanofi will announce a new coronavirus initiative within the next two weeks, its chief executive said on Thursday, adding that it wants to present something concrete and not add to "fantasies".

Drugmaker Sanofi expects further profit growth from narrowed focus

PARIS French drugmaker Sanofi on Thursday forecast further profit growth for 2020 even as it drops some research in areas such as diabetes in a shake-up to narrow its focus on blockbuster treatments including eczema medicine Dupixent.

French drugmaker Sanofi working on coronavirus initiative

PARIS French drugmaker Sanofi will announce a new coronavirus initiative within the next two weeks, its chief executive said on Thursday, adding that it wants to present something concrete and not add to "fantasies".

French drugmaker Sanofi working on coronavirus initiative

PARIS, Feb 6 French drugmaker Sanofi will announce a new coronavirus initiative within the next two weeks, its chief executive said on Thursday, adding that it wants to present something concrete and not add to "fantasies".

UPDATE 2-Drugmaker Sanofi expects further profit growth from narrowed focus

PARIS, Feb 6 French drugmaker Sanofi on Thursday forecast further profit growth for 2020 even as it drops some research in areas such as diabetes in a shake-up to narrow its focus on blockbuster treatments including eczema medicine Dupixent.

Sanofi eyes more growth this year as it narrows focus

PARIS, Feb 6 Sanofi on Thursday said it was expecting earnings per share to grow around 5 percent at constant exchange rates in 2020, weeks after pledging to focus on vaccines and key treatments like its eczema medicine Dupixent until 2022.

Select another date: